Tivity Health Inc. investor allegations that the company painted too rosy a picture of its 2019 Nutrisystem Inc. acquisition should be resolved in a trial, a federal judge ruled.
A reasonable juror could find that the wellness company and then-executives “intentionally misconstrued Tivity’s goodwill and Nutrisystem tradename values” to conceal that the $1.3 billion deal wasn’t as beneficial as executives had claimed, Judge
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.